Assignee
WUHAN YZY BIOPHARMA CO LTD
CN·9 granted patents·11 pending applications·79 citations·filing 2012–2022
Top patents by PatentIndex Score
20 records- 0195US9079965B2Bispecific antibodyWUHAN YZY BIOPHARMA CO LTD·Filed 2014·Granted Jul 14, 2015·47 cites·8 claims
- 0289US9777073B2Construction and application of bispecific antibody EpCAM×CD3WUHAN YZY BIOPHARMA CO LTD·Filed 2015·Granted Oct 3, 2017·8 cites·2 claims
- 0388US10118964B2Construction and application of bispecific antibody HER2xCD3WUHAN YZY BIOPHARMA CO LTD·Filed 2017·Granted Nov 6, 2018·5 cites·6 claims
- 0488US9611325B2Construction and application of bispecific antibody HER2xCD3WUHAN YZY BIOPHARMA CO LTD·Filed 2015·Granted Apr 4, 2017·6 cites·4 claims
- 0587US9562110B2Bispecific antibodyWUHAN YZY BIOPHARMA CO LTD·Filed 2012·Granted Feb 7, 2017·10 cites·8 claims
- 0677US10556964B2Bispecific antibody-mediated cancer therapy with cytokine-induced killer cellWUHAN YZY BIOPHARMA CO LTD·Filed 2014·Granted Feb 11, 2020·3 cites·9 claims
- 0760US2020071421A1Bispecific antibodyWUHAN YZY BIOPHARMA CO LTD·Filed 2019·Application pending·0 cites
- 0860US2022332757A1Split intein and preparation method for recombinant polypeptide using the sameWUHAN YZY BIOPHARMA CO LTD·Filed 2020·Application pending·0 cites
- 0958US2022340677A1Split intein and preparation method for recombinant polypeptide using the sameWUHAN YZY BIOPHARMA CO LTD·Filed 2020·Application pending·0 cites
- 1058US2024247043A1Lag-3 protein mutant, and preparation and use thereofWUHAN YZY BIOPHARMA CO LTD·Filed 2022·Application pending·0 cites
- 1155US12331119B2Modified Fc fragment, antibody comprising same, and application thereofWUHAN YZY BIOPHARMA CO LTD·Filed 2019·Granted Jun 17, 2025·0 cites·8 claims
- 1255US2023080842A1Tetravalent symmetric bispecific antibodiesWUHAN YZY BIOPHARMA CO LTD·Filed 2022·Application pending·0 cites
- 1354US11639388B2CD3 antigen binding fragment and application thereofWUHAN YZY BIOPHARMA CO LTD·Filed 2019·Granted May 2, 2023·0 cites·5 claims
- 1454US2017226222A1Bispecific antibodyWUHAN YZY BIOPHARMA CO LTD·Filed 2017·Application pending·0 cites
- 1554US2025002605A1Bispecific antibody and use thereofWUHAN YZY BIOPHARMA CO LTD·Filed 2021·Application pending·0 cites
- 1653US2025026820A1ANTI-TGFbeta ANTIBODY AND PREPARATION METHOD AND APPLICATION THEREOFWUHAN YZY BIOPHARMA CO LTD·Filed 2021·Application pending·0 cites
- 1749US2023192903A1Bispecific antibody against cldn18.2 and cd3WUHAN YZY BIOPHARMA CO LTD·Filed 2020·Application pending·0 cites
- 1849US2024117061A1Anti-bcma antibody, preparation method therefor and application thereofWUHAN YZY BIOPHARMA CO LTD·Filed 2020·Application pending·0 cites
- 1945US10793619B2Preparation and selection of cells for producing bispecific antibodiesWUHAN YZY BIOPHARMA CO LTD·Filed 2014·Granted Oct 6, 2020·0 cites·6 claims
- 2037US2015196913A1Microfluidic chip for capturing cells and preparing method thereofWUHAN YZY BIOPHARMA CO LTD·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when WUHAN YZY BIOPHARMA CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →